Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
20
pubmed:dateCreated
2003-10-1
pubmed:abstractText
Soluble guanylyl cyclase (sGC) is a cytosolic enzyme producing the intracellular messenger cyclic guanosine monophosphate (cGMP) on activation with nitric oxide (NO). sGC is an obligatory heterodimer composed of alpha and beta subunits. We investigated human beta1 sGC transcriptional regulation in BE2 human neuroblastoma cells. The 5' upstream region of the beta1 sGC gene was isolated and analyzed for promoter activity by using luciferase reporter constructs. The transcriptional start site of the beta1 sGC gene in BE2 cells was identified. The functional significance of consensus transcriptional factor binding sites proximal to the transcriptional start site was investigated by site deletions in the 800-bp promoter fragment. The elimination of CCAAT-binding factor (CBF) and growth factor independence 1 (GFI1) binding cores significantly diminished whereas deletion of the NF1 core elevated the transcription. Electrophoretic mobility-shift assay (EMSA) and Western analysis of proteins bound to biotinated EMSA probes confirmed the interaction of GFI1, CBF, and NF1 factors with the beta1 sGC promoter. Treatment of BE2 cells with genistein, known to inhibit the CBF binding to DNA, significantly reduced protein levels of beta1 sGC by inhibiting transcription. In summary, our study represents an analysis of the human beta1 sGC promoter regulation in human neuroblastoma BE2 cells and identifies CBF as a critically important factor in beta1 sGC expression.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/14504408-10373466, http://linkedlifedata.com/resource/pubmed/commentcorrection/14504408-10411855, http://linkedlifedata.com/resource/pubmed/commentcorrection/14504408-10571030, http://linkedlifedata.com/resource/pubmed/commentcorrection/14504408-10642273, http://linkedlifedata.com/resource/pubmed/commentcorrection/14504408-10660616, http://linkedlifedata.com/resource/pubmed/commentcorrection/14504408-10807655, http://linkedlifedata.com/resource/pubmed/commentcorrection/14504408-10831836, http://linkedlifedata.com/resource/pubmed/commentcorrection/14504408-10984516, http://linkedlifedata.com/resource/pubmed/commentcorrection/14504408-11120376, http://linkedlifedata.com/resource/pubmed/commentcorrection/14504408-11209068, http://linkedlifedata.com/resource/pubmed/commentcorrection/14504408-11526122, http://linkedlifedata.com/resource/pubmed/commentcorrection/14504408-11532916, http://linkedlifedata.com/resource/pubmed/commentcorrection/14504408-11741938, http://linkedlifedata.com/resource/pubmed/commentcorrection/14504408-11810106, http://linkedlifedata.com/resource/pubmed/commentcorrection/14504408-11896586, http://linkedlifedata.com/resource/pubmed/commentcorrection/14504408-11997672, http://linkedlifedata.com/resource/pubmed/commentcorrection/14504408-12149265, http://linkedlifedata.com/resource/pubmed/commentcorrection/14504408-12358775, http://linkedlifedata.com/resource/pubmed/commentcorrection/14504408-12368293, http://linkedlifedata.com/resource/pubmed/commentcorrection/14504408-12436434, http://linkedlifedata.com/resource/pubmed/commentcorrection/14504408-12482752, http://linkedlifedata.com/resource/pubmed/commentcorrection/14504408-12571105, http://linkedlifedata.com/resource/pubmed/commentcorrection/14504408-12655176, http://linkedlifedata.com/resource/pubmed/commentcorrection/14504408-12655181, http://linkedlifedata.com/resource/pubmed/commentcorrection/14504408-170677, http://linkedlifedata.com/resource/pubmed/commentcorrection/14504408-2072909, http://linkedlifedata.com/resource/pubmed/commentcorrection/14504408-239404, http://linkedlifedata.com/resource/pubmed/commentcorrection/14504408-2560585, http://linkedlifedata.com/resource/pubmed/commentcorrection/14504408-2872214, http://linkedlifedata.com/resource/pubmed/commentcorrection/14504408-6147363, http://linkedlifedata.com/resource/pubmed/commentcorrection/14504408-7520478, http://linkedlifedata.com/resource/pubmed/commentcorrection/14504408-7557022, http://linkedlifedata.com/resource/pubmed/commentcorrection/14504408-8717637, http://linkedlifedata.com/resource/pubmed/commentcorrection/14504408-8997507, http://linkedlifedata.com/resource/pubmed/commentcorrection/14504408-9124595, http://linkedlifedata.com/resource/pubmed/commentcorrection/14504408-9214632, http://linkedlifedata.com/resource/pubmed/commentcorrection/14504408-9458697, http://linkedlifedata.com/resource/pubmed/commentcorrection/14504408-9498488, http://linkedlifedata.com/resource/pubmed/commentcorrection/14504408-9566867, http://linkedlifedata.com/resource/pubmed/commentcorrection/14504408-9742212, http://linkedlifedata.com/resource/pubmed/commentcorrection/14504408-9823337
pubmed:keyword
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:day
30
pubmed:volume
100
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
11523-8
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2003
pubmed:articleTitle
CCAAT-binding factor regulates expression of the beta1 subunit of soluble guanylyl cyclase gene in the BE2 human neuroblastoma cell line.
pubmed:affiliation
Department of Integrative Biology and Pharmacology and Institute of Molecular Medicine, University of Texas Medical School, 6431 Fannin, Houston, TX 77030, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't